Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.19 USD | +0.97% | -1.70% | -62.77% |
May. 31 | Verve Therapeutics Names Troy Lister Chief Scientific Officer | MT |
May. 31 | Verve Therapeutics, Inc. Announces Executive Changes | CI |
Chart: Technical Analysis
Technical analysis trends
Short Term | Mid-Term | Long Term | |
---|---|---|---|
Trend | Bearish | Bearish | Bearish |
Resistance | 6.000 | 8.750 | 11.01 |
Spread/Res. | -13.50% | -40.69% | -52.86% |
Spread/Supp. | +2.17% | +2.17% | +37.30% |
Support | 5.080 | 5.080 | 3.780 |
Technical Rankings Surperformance
Short Term Timing | |
---|---|
Middle Term Timing | |
Long Term Timing | |
RSI | |
Bollinger Spread | |
Unusual Volumes |
- Stock Market
- Equities
- VERV Stock
- Charts Verve Therapeutics, Inc.